Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03353649 · ClinicalTrials.gov registry record · NA

Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Binge Eating and Smoking

A NA study of Behavior and Smoking, Tobacco, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
115
Enrollment target
1
Study location

NCT03353649 is a NA study of Behavior and Smoking, Tobacco that has completed, run by Stanford University. The registered enrollment target is 115 participants, below the 4,860-participant average among 23 other Behavior trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03353649, a NA study of Behavior and Smoking, Tobacco, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
115 participants
Enrollment target
1
Study location

Study Summary

This study aims to examine targets of self-regulatory function among two exemplar populations for which behavior plays a critical role in health outcomes: smokers and individual who binge eat (BED). This is the second phase of a study that aims to identify putative mechanisms of behavior change to develop an overarching "ontology" of self-regulatory processes.

Interventions

  • DEVICE fMRI
  • BEHAVIORAL Now vs. Later Cue

Study Locations (1)

California

  • Stanford CNI - Stanford

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2017-12-08
Est. Completion 2018-01-14
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03353649

The ClinicalTrials.gov registry entry for NCT03353649 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,860-participant average among 23 other Behavior trials with a reported enrollment target (98% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Behavior appearing as the primary indexed condition, and to 2 interventions - of which fMRI is the first listed.

NCT03353649 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03353649 about?

NCT03353649 is a clinical study titled "Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Binge Eating and Smoking". This study aims to examine targets of self-regulatory function among two exemplar populations for which behavior plays a critical role in health outcomes: smokers and individual who binge eat (BED). This is the second phase of a study that aims to identify putative mechanisms of behavior change to d...

What is the current status of trial NCT03353649?

This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2017-12-08. Estimated completion is 2018-01-14.

What conditions does trial NCT03353649 study?

This clinical trial studies the following conditions: Behavior, Smoking, Tobacco, Binge Eating.

What interventions are being tested in trial NCT03353649?

The interventions under investigation include: fMRI (DEVICE), Now vs. Later Cue (BEHAVIORAL).

Who is sponsoring clinical trial NCT03353649?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03353649 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.